Europe Tracheostomy Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The Europe tracheostomy market was valued at US$ 168.31 million in 2023 and is expected to reach US$ 267.17 million by 2031; it is estimated to register a CAGR of 5.9% from 2023 to 2031.

Increasing Prevalence of Respiratory Diseases Drives Europe Tracheostomy Market

Advanced stages in conditions such as lung cancer, asthma, and chronic obstructive pulmonary disease (COPD) often require tracheostomy procedures for ventilation support. In addition, severe cases of infectious diseases such as tuberculosis, pneumonia, and influenza lead to respiratory failure, thereby increasing the need for tracheostomy. Critically ill patients suffering from COVID-19 infection require ventilation supported by tracheostomy. As per the World Cancer Research Fund International, in 2023, lung cancer became the most common type of cancer worldwide. In 2022, there were 2,480,675 new cases of lung cancer.

In 2022, the global incidence of lung cancer varied widely among countries. China had the highest burden, with 1,060,584 reported cases and 733,291 deaths. The United States followed with 226,033 cases and 127,653 deaths. Japan recorded 136,723 cases and 83,243 deaths, while India had 81,748 cases and 75,031 deaths. The Russian Federation reported 70,362 cases with 51,887 deaths, and Germany had 62,025 cases and 47,731 deaths. The United Kingdom reported 50,700 cases and 35,394 deaths, while France (Metropolitan) had 49,613 cases and 36,876 deaths. Brazil recorded 44,213 cases and 38,292 deaths, and Italy had 43,808 cases with 35,668 deaths. These data were sourced from the World Cancer Research Fund International in collaboration with the World Health Organization.

In addition, as per the World Health Organization (WHO), in 2023, approximately 10.8 million (6 million men, 3.6 million women, and 1.3 million children) patients were suffering from tuberculosis. Thus, the increasing prevalence of respiratory diseases creates a burden on healthcare systems, thereby bolstering the demand for tracheostomy treatments.

Europe Tracheostomy Market Overview

In Germany, a significant number of people have chronic respiratory conditions such as COPD and sleep apnea, which has led to an increased need for tracheostomy procedures. An article published in Somnologie in 2023 highlighted that obstructive sleep apnea (OSA) is a prevalent chronic disorder and an independent risk factor for various health issues, with a high estimated prevalence of 30% for men and 13% for women in Germany.

Germany's advanced healthcare system and extensive ICU capacity have had a positive impact on the tracheostomy market, as many patients requiring long-term ventilation care derive benefits from these devices. Overall, Germany continues to be one of the primary markets for tracheostomy products in Europe, driven by clinical demand and technological advancements. The availability of significant local and international manufacturers, including Primed Halberstadt Medizintechnik GmbH and Randouml SE and Co. KG, is anticipated to drive the growth of the market.

Europe Tracheostomy Market: Strategic Insights

Europe Tracheostomy Market Segmentation Analysis:

The Europe tracheostomy market is categorized into type, technique, end user, and country.

Based on types, the Europe tracheostomy market is segmented into tracheostomy tubes, tracheostomy ventilation accessories, other accessories, and tracheostomy clean and care kits. The tracheostomy tubes segment held the largest market share in 2023.

In terms of technique, the Europe tracheostomy market is bifurcated into surgical tracheostomy and percutaneous dilatational tracheostomy. The percutaneous dilatational tracheostomy segment held a larger market share in 2023.

By hospital type, the Europe tracheostomy market is bifurcated hospitals and surgery centers, ambulatory care centers, home care settings, and research laboratories and academic institutes. The hospitals and surgery centers segment held the largest market share in 2023.

By country, the Europe tracheostomy market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe tracheostomy market share in 2023.

Europe Tracheostomy Market Players Density: Understanding Its Impact on Business Dynamics

The Europe Tracheostomy Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Company Profiles

AdvaCare Pharma USA LLC; Andreas Fahl Medizintechnik-Vertrieb GmbH; Angiplast; Boston Medical Products Inc; Coloplast Corp; Cook Medical Holdings LLC; Fisher & Paykel Healthcare Corp Ltd; Fuji Systems Corporation; ICU Medical Inc; Intersurgical Ltd; Kapitex Healthcare Limited; Medtronic Plc; SunMed Group Holdings LLC ( AirLife); Teleflex Inc; Tianjin Medis Medical Device Co. Ltd.; Troge Medical GmbH; VBM Medizintechnik GmbH; and Well Lead Medical Co. Ltd. are among the leading companies operating in the tracheostomy market.